• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: News

  • Audio Journal of Oncology Volume 16 Number 11
    • in Oncology
    • — 3 Jun, 2008

    Audio Journal of Oncology Volume 16 Number 11

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)

    Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology Annual Meeting, May 30-June 3, 2008, Chicago

    Michael Gnant
    Michael Gnant

    In this edition:

    1. Zoledronic …

    Read more
    Audio Journal of Oncology Volume 16 Number 9
    • in Oncology
    • — 26 Apr, 2008

    Audio Journal of Oncology Volume 16 Number 9

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
    Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam

    Angel Rodriguez
    Angel Rodriguez

    In this edition:

    1. Lapatinib: Targets Breast Cancer Stem Cells?

    Angel Rodriguez, Baylor College, Houston…

    Read more
  • Risks From Stopping Cancer Trials Early!
    • in London School of Hygiene & Tropical Medicine
    • — 9 Apr, 2008

    Risks From Stopping Cancer Trials Early!

    Giovanni Apolone
    Giovanni Apolone

    In this edition of Audio News, presented by Peter Goodwin, Giovanni Apolone (Mario Negri Institute, Milan) and Stuart Pocock (London School of Hygiene and Tropical Medicine), talk about:

    Risks From Stopping Cancer Trials Early!
    – A report from

    …
    Read more
    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH:
    Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML

    Richard Stone
    Richard Stone

    RICHARD STONE, Dana-Farber Cancer Institute, Boston
    GEORGE CANELLOS, Dana-Farber Cancer Institute

    New data shows that dasatinib is giving durable responses in patients with chronic phase chronic myeloid leukemia who have failed, or who cannot tolerate imatinib. So where
    …
    Read more
  • Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes
    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

    Pierre Fenaux
    Pierre Fenaux

    PIERRE FENAUX, Paris 13 University
    Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University
    …
    Read more
    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH:
    Interleukin-2 For Acute Myeloid Leukemia In First Remission?

    Jonathan Kolitz
    Jonathan Kolitz

    JONATHAN KOLITZ, Monter Cancer Center, Lake Success, NY
    GEORGE CANELLOS, Dana-Farber Cancer Institute

    For patients with acute myeloid leukemia in first remission, new data suggests that there may be a benefit from interleukin-2. Derek Thorne got the interim
    …
    Read more
  • New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
    • in General Medicine
    • — 9 Dec, 2007

    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

    Terry Gernsheimer
    Terry Gernsheimer

    TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
    An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
    …
    Read more
    No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia
    • in Public Health
    • — 9 Dec, 2007

    No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

    Zakari Aliyu
    Zakari Aliyu

    REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
    ZAKARI ALIYU, Howard University, Washington DC
    Nigeria has the highest incidence of sickle cell anemia in the world, with over 150,000 children being born each year with
    …
    Read more
  • TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
    • in Cardiovascular
    • — 5 Nov, 2007

    TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?

    Gordon Tomaselli
    Gordon Tomaselli
    Daniel Jones
    Daniel Jones

    REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
    GORDON TOMASELLI, Johns Hopkins University, Baltimore
    COMMENT: DANIEL JONES, President, American Heart Association, University of Mississippi, Jackson

    A potential new
    …
    Read more
    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer
    • in Oncology
    • — 16 Oct, 2007

    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

    Jose Baselga
    Jose Baselga
    Gordon McVie
    Gordon McVie

    REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    Neoadjuvant trastuzumab for patients with HER2-positive
    …
    Read more
  • Laparoscopic-Assisted Resection for Colorectal Cancer
    • in Oncology
    • — 26 Sep, 2007

    Laparoscopic-Assisted Resection for Colorectal Cancer

    Pierre Guillou
    Pierre Guillou
    David Jayne
    David Jayne

    REFERENCE: J Clin Oncol 25:3061-3068
    PIERRE GUILLOU, St James’ Hospital, Leeds
    COMMENT: DAVID JAYNE, St James’ Hospital, Leeds

    Laparoscopic-assisted resection for colorectal cancer has proved just as effective as conventional open surgery, according to researchers in
    …
    Read more
    Vancomycin: New Guidelines May Induce Kidney Damage
    • in Public Health
    • — 19 Sep, 2007

    Vancomycin: New Guidelines May Induce Kidney Damage

    Megan Nguyen
    Megan Nguyen

    REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    MEGAN NGUYEN, Western University in Pomona, California
    New vancomycin guidelines that recommend using higher doses may cause kidney damage according to
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: News

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.